SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?

Resistant hypertension is, by definition, a challenge to most physicians treating hypertension. Renal sympathetic denervation has shown promising early results in treating this condition. The SYMPLICITY HTN-3 is the most recent trial to report the effects of this technique on resistant hypertension....

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Hitesh C, Hayward, Carl, Di Mario, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bloomsbury Qatar Foundation Journals 2014
Materias:
Lessons from the Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104384/
https://www.ncbi.nlm.nih.gov/pubmed/25054126
http://dx.doi.org/10.5339/gcsp.2014.15
_version_ 1782327252281720832
author Patel, Hitesh C
Hayward, Carl
Di Mario, Carlo
author_facet Patel, Hitesh C
Hayward, Carl
Di Mario, Carlo
author_sort Patel, Hitesh C
collection PubMed
description Resistant hypertension is, by definition, a challenge to most physicians treating hypertension. Renal sympathetic denervation has shown promising early results in treating this condition. The SYMPLICITY HTN-3 is the most recent trial to report the effects of this technique on resistant hypertension. This review discusses this study and its surprising neutral results before ending with an overview of key lessons learned.
format Online
Article
Text
id pubmed-4104384
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Bloomsbury Qatar Foundation Journals
record_format MEDLINE/PubMed
spelling pubmed-41043842014-07-22 SYMPLICITY HTN 3: The death knell for renal denervation in hypertension? Patel, Hitesh C Hayward, Carl Di Mario, Carlo Glob Cardiol Sci Pract Lessons from the Trials Resistant hypertension is, by definition, a challenge to most physicians treating hypertension. Renal sympathetic denervation has shown promising early results in treating this condition. The SYMPLICITY HTN-3 is the most recent trial to report the effects of this technique on resistant hypertension. This review discusses this study and its surprising neutral results before ending with an overview of key lessons learned. Bloomsbury Qatar Foundation Journals 2014-01-29 /pmc/articles/PMC4104384/ /pubmed/25054126 http://dx.doi.org/10.5339/gcsp.2014.15 Text en © 2014 Patel, Hayward, Di Mario, licensee Bloomsbury Qatar Foundation Journals. This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Lessons from the Trials
Patel, Hitesh C
Hayward, Carl
Di Mario, Carlo
SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?
title SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?
title_full SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?
title_fullStr SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?
title_full_unstemmed SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?
title_short SYMPLICITY HTN 3: The death knell for renal denervation in hypertension?
title_sort symplicity htn 3: the death knell for renal denervation in hypertension?
topic Lessons from the Trials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104384/
https://www.ncbi.nlm.nih.gov/pubmed/25054126
http://dx.doi.org/10.5339/gcsp.2014.15
work_keys_str_mv AT patelhiteshc symplicityhtn3thedeathknellforrenaldenervationinhypertension
AT haywardcarl symplicityhtn3thedeathknellforrenaldenervationinhypertension
AT dimariocarlo symplicityhtn3thedeathknellforrenaldenervationinhypertension

Ejemplares similares